Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy

NCT07222280 is registered in ClinicalTrials.gov with Covenant Health, US as lead sponsor.

NCT NCT07222280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Lead sponsor
Covenant Health, US
Phase
Not applicable
Overall status
Recruiting
Start date
June 10, 2025
Completion date
March 31, 2026
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer disease, cognitive abnormality, delirium confusional state, encephalopathy